Cellectis SA (CLLS)
2.620
-0.02
(-0.77%)
USD |
NASDAQ |
Apr 23, 16:00
2.58
-0.04
(-1.52%)
After-Hours: 20:00
Cellectis Net Income (TTM): -85.02M for Sept. 30, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
Date | Value |
---|---|
September 30, 2023 | -85.02M |
June 30, 2023 | -96.00M |
March 31, 2023 | -104.30M |
December 31, 2022 | -106.14M |
September 30, 2022 | -104.32M |
June 30, 2022 | -113.27M |
March 31, 2022 | -134.24M |
December 31, 2021 | -114.20M |
September 30, 2021 | -128.67M |
June 30, 2021 | -121.55M |
March 31, 2021 | -113.90M |
December 31, 2020 | -81.95M |
September 30, 2020 | -79.87M |
June 30, 2020 | -65.57M |
March 31, 2020 | -66.75M |
December 31, 2019 | -102.08M |
Date | Value |
---|---|
September 30, 2019 | -87.96M |
June 30, 2019 | -94.77M |
March 31, 2019 | -68.58M |
December 31, 2018 | -78.77M |
September 30, 2018 | -82.60M |
June 30, 2018 | -85.95M |
March 31, 2018 | -105.20M |
December 31, 2017 | -99.53M |
September 30, 2017 | -85.78M |
June 30, 2017 | -73.68M |
March 31, 2017 | -54.13M |
December 31, 2016 | -67.76M |
September 30, 2016 | -44.81M |
June 30, 2016 | -45.12M |
March 31, 2016 | -63.02M |
December 31, 2015 | -22.98M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-134.24M
Minimum
Mar 2022
-65.57M
Maximum
Jun 2020
-100.03M
Average
-103.19M
Median
Net Income (TTM) Benchmarks
DBV Technologies SA | -72.73M |
Biophytis SA | -18.44M |
Genfit SA | -- |
Edap TMS SA | -22.90M |
Biodexa Pharmaceuticals Plc | -8.826M |